What is "telik"

Telik, Inc. ( NASDAQ:TELK), was set up in 1988 and now is headquartered in Palo Alto, California, a clinical-stage drug manufacturing company. The major drug of the company is TELINTRA, an investigational agent in development for the treatment of myelodysplastic syndrome (MDS) and idiopathic chronic neutropenia.